BlackRock Investment Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$554K Buy
42,761
+481
+1% +$7.41K ﹤0.01% 3017
2016
Q3
$691K Sell
42,280
-72
-0.2% -$1.3K ﹤0.01% 2873
2016
Q2
$525K Buy
42,352
+22,169
+110% +$277K ﹤0.01% 3041
2016
Q1
$216K Buy
20,183
+9,912
+97% +$90.2K ﹤0.01% 3145
2015
Q4
$151K Buy
+10,271
New +$126K ﹤0.01% 3252

Other funds holding MYOK

BlackRock Investment Management's MYOK Position: Q4 2016 in Review

BlackRock Investment Management increased its MyoKardia, Inc. Common Stock (MYOK) stake by 1.1% in Q4 2016, buying an estimated $7.41K and bringing the position to 42,761 shares worth $554K. The position accounts for ﹤0.01% of the portfolio, ranked #3017.

BlackRock Investment Management first reported a position in MYOK in Q4 2015 and has held it in 5 quarters since. The position peaked at $691K in Q3 2016. 71 funds tracked by Wall St. Rank hold MYOK as of Q4 2016.

  • BlackRock Investment Management held 42,761 shares of MyoKardia, Inc. Common Stock worth $554K as of Q4 2016.
  • BlackRock Investment Management bought 481 MyoKardia, Inc. Common Stock shares in Q4 2016, an estimated $7.41K.
  • MyoKardia, Inc. Common Stock made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3017 holding.
  • BlackRock Investment Management first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Investment Management's MyoKardia, Inc. Common Stock position peaked at $691K in Q3 2016.
  • 71 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.